CompletedPHASE2, PHASE3NCT00179829

WT1 for the Detection of Minimal Residual Disease

Studying Acute lymphoblastic leukemia

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Ann & Robert H Lurie Children's Hospital of Chicago
Principal Investigator
Morris Kletzel, MD
Ann & Robert H Lurie Children's Hospital of Chicago
Intervention
WT 1 Testing(procedure)
Enrollment
50 enrolled
Eligibility
21 years · All sexes
Timeline
19992006

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT00179829 on ClinicalTrials.gov

Other trials for Acute lymphoblastic leukemia

Additional recruiting or active studies for the same condition.

See all trials for Acute lymphoblastic leukemia

← Back to all trials